The Clock Is Ticking: Countdown to Metastases

1. Perou C. M., Sorlie T., Eisen M. B., van de Rijn M. Jeffrey S. S., Rees C. A., Pollack J. R., Ross D. T., Johnsen H., Akslen L. A., Fluge O., Pergamenschikov A., Williams C., Zhu S. X., Lonning P. E., Borresen-Dale A. L., Brown P. O., Botstein D. Molecular portraits of human breast tumours. Nature. 2000;406:747–52. 10963602

2. Varmbally S., Yu J., Laxman B., Rhodes D. R., Mehra R., Tomlins S. A., Shah R. B., Chandran U., Monzon F. A., Becich M. J., Wei J. T., Pienta K. J., Ghosh D., Rubin M. A., Chinnaiyan A. M. Integrative genomic and proteomic analysis of prostate cancer reveals signatures of metastatic progression. Cancer Cell. 2005;8:393–406. 16286247

3. Paik S., Shak S., Tang G., Kim C., Baker J., Cronin M., Baehner F. L., Walker M. G., Watson D. Park T., Hiller W., Fisher E. R., Wickerman D. L., Bryant J., Wolmark N. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med. 2004;35:2817–26.

4. Hunter K. W., Broman K. W., Voyer T. L., Lukes L., Cozma D., Debies M. T., Rouse J., Welch D. R. Predisposition to efficient mammary tumor metastatic progression is linked to the breast cancer metastasis suppressor gene Brms1. Cancer Res. 2001;61:8866–72. 11751410

5. Guy C. T., Cardiff R. D., Muller W. J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol Cell Biol. 1992;12:954–61. 1312220

6. Hu Y., Bai L., Geiger T., Goldberger N. Walker R. C., Green J. E., Wakefield L. M., Hunter K. W. Genetic background may contribute to PAM50 gene expression breast cancer subtype assignments. PLoS ONE. 2013;8:e72287. doi: 10.1371/journal.pone.0072287 24015230

7. Ha N-H., Long J., Cai Q., Shu X. O., Hunter K. W. The circadian rhythm gene Arntl2 is a metastasis susceptibility gene for estrogen receptor-negative breast cancer. PLoS Genet. 2016; 12(9): e1006267.

8. Takahashi J. S. Molecular components of the circadian clock in mammals. Diabetes Obes Metab. 2015;17 Suppl:6–11.

9. Faraji F., Pang Y., Walker R. C., Borges R. N., Yang L, Hunter K. W. Cadm1 is a metastasis susceptibility gene that suppressed metastasis by modifying tumor interaction with the cell-mediated immunity. PLoS Genet. 2012;8:e1002926. doi: 10.1371/journal.pgen.1002926 23028344

10. Brady J. J., Chuang C-H., Greenside P. G., Rogers Z. N., Murray C. W., Caswell D. R., Hartmann U., Connolly A. J., Sweet-Cordero E. A., Kundaje A., Winslow M. M.,. An Arntl2-driven secretome enables lung adenocarcinoma metastatic self-sufficiency. Cancer Cell. 2016;29:697–710. doi: 10.1016/j.ccell.2016.03.003 27150038

11. Mazzoccoli G., Pazienza V., Panza A., Valvano M. R., Benegiao G., Vinciguerra M., Andriulli A., Piepoli A. ARNTL2 and SERPINE1: potential biomarkers for tumor aggressiveness in colorectal cancer. J Cancer Res Clin Oncol. 2012;138:501–11. doi: 10.1007/s00432-011-1126-6 22198637

12. Karantanos T., Theodoropoulus G., Pektasides D., Gazouli M. Clock genes: their role in colorectal cancer. World J Gastroenterol. 2014;20:1986–92. doi: 10.3748/wjg.v20.i8.1986 24587674

13. Valenzuela F. J., Vera J., Venegas C., Munoz S., Oyarce S., Munoz K., Lagunas C. Evidences of polymorphism associated with cricadian system and risk of pathologies: a review of the literature. Int J Endo. 2016;2016:2746909.

14. Tung N., Domchek S. M., Stadler Z., Nathanson K. L., Couch F., Garber J. E., Offit K., Robson M. E. Counselling framework for moderate-penetrance cancer-susceptibility mutations. Nat Rev Clin Oncol. 2016;13(9):581–8. doi: 10.1038/nrclinonc.2016.90 27296296

15. de Jong M. M., Nolte I., te Meerman G. J., van der Graaf W. T. A., Oosterwijk J., Kleibeuker J., Schaapveld M., de Vries E. G. E. Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility. J Med Genet. 2002;39:225–42. 11950848

16. Faraji F., Hu Y., Wu G., Goldberger N. E., Walker R. C., Zhang J., Hunter K. W. An integrated systems genetics screen reveals the transcriptional structure of inherited predisposition to metastatic disease. Genome Res. 2014;24:227–40. doi: 10.1101/gr.166223.113 24322557

17. Hsiesh S.-M., Look M. P., Sieuwerts A. M., Foekens J. A., Hunter K. W. Distinct inherited metastasis susceptibility exists for different breast cancer subtypes: a prognosis study. Breast Cancer Res. 2009;11:R75. doi: 10.1186/bcr2412 19825179

18. Lee M., Williams K. A., Hu Y., Andreas J., Patel S. J., Zhang S., Crawford N. P. GNL3 and SKA3 are novel prostate cancer metastasis susceptibility genes. Clin Exp Mets. 2015;32:769–82.

19. Kelleher F. C., Rao A., Maguire A. Circadian molecular clocks and cancer. Cancer Lett. 2014;342:9–18. doi: 10.1016/j.canlet.2013.09.040 24099911

20. Ortiz-Tudela E., Mteyrek A., Ballesta A., Innominato P. F., Levi F. Cancer chronotherapeutics: experimental, theoretical, and clinical aspects. Handb Exp Pharmacol. 2013;217:261–88. doi: 10.1007/978-3-642-25950-0_11 23604483